Fatal Overdose Reduction Act of 2025
- Bill Number
- S. 665
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-02-20: Read twice and referred to the Committee on Finance.
- Last Updated
- 2026-04-10T16:18:20Z
AI-Generated Summary
Purpose
The Fatal Overdose Reduction Act of 2025 aims to address the opioid and substance use disorder crisis by establishing a demonstration program under Medicaid (the federal-state health insurance program for low-income individuals). It creates "Health Engagement Hubs" to provide accessible, drop-in treatment and support services, particularly in high-need communities, to increase engagement in care and reduce overdose deaths.
Key Provisions
- Guidance and Certification: Within 6 months of enactment, the Secretary of Health and Human Services (HHS) must publish criteria for states to certify organizations as Health Engagement Hubs. These hubs must serve Medicaid-eligible individuals (enrolled or not), uninsured people, and prioritize locations in areas hit hard by overdoses, such as rural, tribal, homeless, or justice-impacted communities. Hubs use evidence-based approaches like motivational interviewing (a counseling technique to encourage behavior change).
- Required Services: Hubs provide a range of walk-in services during non-traditional hours (e.g., evenings/weekends), including:
- Harm reduction (e.g., overdose reversal drugs like naloxone, safer use supplies).
- Behavioral and physical health care (e.g., mental health screening, wound care, infectious disease testing for HIV/hepatitis, sexual health services).
- Medication management for substance use disorders, targeted case management (coordinating care), peer support (from people with lived experience), and community outreach.
- Optional social needs support (e.g., help with ID, employment, family reunification, legal aid).
- Access to approved medications for treatment within 4 hours, via direct provision or partnerships.
- Prescribed drugs are paid separately from other services.
- Staffing and Operations: Minimum staff includes a prescribing health provider, nurse, behavioral health specialist, peer support/recovery coach (prioritizing those with lived substance use experience), and outreach navigators (at least 50% with lived experience). Hubs need 12 months of prior experience in substance use treatment and a community advisory board with monthly/quarterly input from affected individuals. Uninsured services use a sliding-scale fee based on ability to pay, without denial for inability to pay.
- Funding and Implementation:
- $60 million appropriated for planning grants to states, technical assistance, data collection, and HHS administration.
- Up to 10 states selected (prioritizing high overdose rates and geographic diversity) for 5-year programs, starting 9 months after planning grants.
- States must target high-overdose or mental health shortage areas (at least 50% of hubs there) and establish a prospective payment system (a fixed upfront rate for bundled services, excluding drugs).
- Federal funding: 90% match (or higher if state's regular rate is better) for hub services to enrolled Medicaid beneficiaries; waivers for statewide coverage and uniform benefits rules.
- Tribal and urban Indian organizations can apply similarly to states.
- Evaluation and Reporting:
- States submit initial implementation data (first 2 years), then annual reports (from year 3) on access, overdose reductions, adherence to treatment, demographics, and recommendations.
- HHS conducts a national evaluation via an independent contractor, including public input and service metrics.
- HHS reports annually to Congress; Government Accountability Office assesses the program after 18 months.
Significant Changes to Existing Law
- Adds a new subsection (cc) to Section 1903 of the Social Security Act, creating the demonstration program as a time-limited test (5 years) of bundled payments for hub services under Medicaid.
- Introduces a prospective payment system for non-drug services, separate from standard Medicaid drug payments (which continue under existing rules, including rebates).
- Waives two Medicaid requirements: statewideness (services must cover the whole state) and comparability (uniform benefits across groups), to allow targeted hub placement.
- Explicitly includes tribal entities in eligibility, aligning with laws like the Indian Self-Determination Act, and mandates lived-experience staffing, which is new for Medicaid-funded programs.
Potential Impacts
- Government Agencies: HHS gains administrative duties for guidance, grants, selections, and evaluations, with $60 million funding. States receive planning support and enhanced federal matching, but must develop payment systems and collect data, potentially straining resources initially. Up to 10 states may see reduced overdose rates and better care coordination.
- Citizens: Improves access to low-barrier treatment for people with opioid/substance use disorders, especially uninsured or underserved groups (e.g., homeless, rural, tribal, justice-involved), potentially lowering mortality, hospitalizations, and improving housing/employment. Uninsured get affordable sliding-scale care.
- International Relations: No direct impact, as this is a domestic health program focused on U.S. substance use issues.
Main Stakeholders Affected
- Individuals with Substance Use Disorders: Primary beneficiaries, gaining walk-in, trauma-informed care and harm reduction to reduce overdoses and support recovery.
- States and Local Governments: Eligible for grants and funding; must apply, certify hubs, and report data; high-overdose areas prioritized.
- Health Engagement Hubs and Providers: Organizations (e.g., clinics, nonprofits) seeking certification to receive bundled payments; includes partnerships with federally qualified health centers or tribal groups.
- Uninsured and Marginalized Communities: Rural, tribal, homeless, and justice-impacted populations, plus those with infectious diseases or social needs.
- Peer Support and Lived-Experience Workers: New hiring priorities, enhancing community-driven care.
- Tribal Organizations: Explicit inclusion for application and participation.
Notable Legal, Constitutional, or Political Implications
- Legal: As a demonstration program, it tests innovative Medicaid delivery without permanent changes, but requires compliance with existing rules (e.g., drug rebates). Prospective payments could set precedents for bundled care models. Includes safeguards against duplicate payments and ensures care continuity.
- Constitutional: No major issues; aligns with Congress's spending power under the General Welfare Clause for public health. Waivers respect federalism by allowing state flexibility while maintaining federal oversight.
- Political: Bipartisan sponsorship (Sens. Cantwell and Cassidy) signals broad support for opioid crisis response. Emphasizes equity (e.g., lived experience, high-need targeting) amid ongoing national overdose epidemic; evaluations could influence future expansions or terminations, affecting policy debates on harm reduction vs. abstinence models.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (1)
Recent Actions
- 2025-02-20: Read twice and referred to the Committee on Finance.
- 2025-02-20: Introduced in Senate
Bill Versions
- Fatal Overdose Reduction Act of 2025 — issued 2025-02-20 — PDF (28 pages)